Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech companies ranked by P/S ratio, at 3.7, followed by Qiagen (4.9) and Neurocrine Biosciences (5.8). Figures as of 18 Nov 2026, 19:21 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.7
Median
14.3
Combined market value
CHF 705.5B
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
CHF
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7CHF 31.3BCHF 211.42 0.08% down 49% up United States
2QiagenQGEN · Health Care4.9CHF 8.7BCHF 41.92 0.13% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.8CHF 14BCHF 137.83 1.53% down 20% up United States
4AmgenAMGN · Health Care6.5CHF 201.9BCHF 373.22 3.39% down 34% up United States
5BioNTechBNTX · Health Care6.5CHF 17.5BCHF 70.72 1.22% down 16% down Germany
6Gilead SciencesGILD · Health Care7.1CHF 176.2BCHF 142.07 1.09% down 33% up United States
7ExelixisEXEL · Health Care7.2CHF 14.1BCHF 57.87 0.14% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9CHF 9.3BCHF 81.23 0.33% up 37% up United States
9Bio-TechneTECH · Health Care9.4CHF 9.6BCHF 61.40 0.21% up 26% up United States
10argenxARGX · Health Care14.3CHF 50.2BCHF 797.97 0.18% down 4% up Belgium
11RepligenRGEN · Health Care14.8CHF 9.2BCHF 144.27 5.44% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.7CHF 3.9BCHF 24.05 0.05% up 88% up United States
13Twist BioscienceTWST · Health Care21.3CHF 6.8BCHF 99.46 5.26% up 340% up United States
14Krystal BiotechKRYS · Health Care23.8CHF 7.8BCHF 264.14 4.87% up 46% up United States
15ModernaMRNA · Health Care41.4CHF 67.9BCHF 167.77 3.84% down 755% up United States
16ImmunityBioIBRX · Health Care62.4CHF 6BCHF 5.60 6.07% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care264CHF 8.7BCHF 102.35 0.16% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1133CHF 3.4BCHF 34.57 2.07% up 21% down Switzerland
19CG OncologyCGON · Health Care1754CHF 6BCHF 66.93 0.51% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8436 CHF). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies have the lowest P/S ratio?

Biogen (3.7), Qiagen (4.9) and Neurocrine Biosciences (5.8) have the lowest P/S ratio of the 19 biotech companies ranked here as of 18 Nov 2026, 19:21 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of CHF 705.5B as of 18 Nov 2026, 19:21 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.